Understanding How the Initial Encounter With Influenza Virus Poises Children for Protective Immunity

Trial Profile

Understanding How the Initial Encounter With Influenza Virus Poises Children for Protective Immunity

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Influenza virus vaccine (Primary) ; MEDI 3250 (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Oct 2017 Status changed from recruiting to active, no longer recruiting.
    • 18 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 28 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top